Malaga Cove Capital, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Malaga Cove Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$6.15 - $10.51 $350,506 - $598,996	-56,993 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$10.32 - $13.06 $6,749 - $8,541	-654 Reduced 1.13%	56,993 $617,000
Q2 2018 Aug 01, 2018	SELL	$7.8 - $13.69 $16,021 - $28,119	-2,054 Reduced 3.44%	57,647 $692,000
Q1 2018 Apr 16, 2018	BUY	$7.86 - $11.39 $2,468 - $3,576	314 Added 0.53%	59,701 $512,000
Q4 2017 Jan 31, 2018	BUY	$8.77 - $12.28 $142,056 - $198,911	16,198 Added 37.5%	59,387 $587,000
Q3 2017 Nov 08, 2017	BUY	$12.17 - $16.3 $525,610 - $703,980	43,189	43,189 $521,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Malaga Cove Capital, LLC with notifications on news.